RUNX3 controls a metastatic switch in pancreatic ductal adenocarcinoma

For the majority of patients with pancreas cancer, the high metastatic proclivity is life-limiting. Some patients, however, present with and succumb to locally destructive disease. A molecular understanding of these distinct disease manifestations can critically inform patient management. Using gene...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cell
Egile Nagusiak: Whittle, Martin C., Izeradjene, Kamel, Rani, P. Geetha, Feng, Libing, Carlson, Markus A., DelGiorno, Kathleen E., Wood, Laura D., Goggins, Michael, Hruban, Ralph H., Chang, Amy E., Calses, Philamer, Thorsen, Shelley M., Hingorani, Sunil R.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2015
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4458240/
https://ncbi.nlm.nih.gov/pubmed/26004068
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cell.2015.04.048
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak